Sunday, March 16.

    • After delays, Teva wins approval from U.S. for migraine treatment

    September 17, 2018 0
    .com/blogger_img_proxy/
    Beleaguered Israeli drug company banking on Ajovy to boost sales, profits and offset the decline of its Copaxone MS treatment
    Read More
    Tags:

    About Awais Jawed

    Post a Comment

  • Blogger
  • Disqus
  • Facebook

    • No comments

    Subscribe to: Post Comments ( Atom )